NEW YORK (GenomeWeb) – Health plan management firm MagnaCare has signed a deal to provide GenTox's pharmacogenomic testing services to members of its provider network, the companies announced today.

"This initiative promises to provide doctors with the valuable information they need to achieve more efficient dosing of critical medications and provides access to information for the most effective choices based upon each patient’s unique genetic makeup obtained through the testing," MagnaCare CEO Joseph Berardo said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.